Antiphospholipid syndrome echocardiography or ultrasound: Difference between revisions
Feham Tariq (talk | contribs) No edit summary |
Feham Tariq (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
*Two dimensional echocardiogram may show aortic or mitral valve insufficiency, which is the most common valvular defect in patients with Libmann Sacks endocarditis. | |||
==Antiphospholipid syndrome echocardiography or ultrasound== | ==Antiphospholipid syndrome echocardiography or ultrasound== |
Revision as of 15:35, 24 April 2018
Antiphospholipid syndrome Microchapters |
Differentiating Antiphospholipid syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Antiphospholipid syndrome echocardiography or ultrasound On the Web |
American Roentgen Ray Society Images of Antiphospholipid syndrome echocardiography or ultrasound |
FDA on Antiphospholipid syndrome echocardiography or ultrasound |
CDC on Antiphospholipid syndrome echocardiography or ultrasound |
Antiphospholipid syndrome echocardiography or ultrasound in the news |
Blogs on Antiphospholipid syndrome echocardiography or ultrasound |
Risk calculators and risk factors for Antiphospholipid syndrome echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Feham Tariq, MD [2]
Overview
- Two dimensional echocardiogram may show aortic or mitral valve insufficiency, which is the most common valvular defect in patients with Libmann Sacks endocarditis.